Anabolic actions of human parathyroid hormone, rhpth (1-34) on the skeleton

• In: Osteoporosis And Fractures (SIGs Nuclear/Radiologic Pharmacy and Pharmacoeconomics/Pharmacoepidemiology) on Wednesday, 8 September 2004, 9:00-12:00
• At: New Orleans (USA) (2004)
• Type: Presentation
• By: HOCK, Janet (Indiana University School of Medicine, Anatomy & Cell Biology, Indianapolis, United States of America)
• Abstract:

  PTH enhances bone quality and reduces fracture risk. Post-menopausal osteoporotic women, treated with human parathyroid hormone, hPTH 1-34 showed highly significant fracture reduction. Knowing human outcomes, perplexing questions on its skeletal effects are re-examined. Is PTH exposure critical? In ovariectomized rats, PTH increased bone mass by

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login